Queen Elizabeth University Hospital: base for new subsidiary


A life sciences company based in California has received £4.5 million from Scottish Enterprise to help create 43 jobs.

Biospyder will receive the package of taxpayer support towards a £10.5m investment in setting up Bioclavis, a subsidiary at the Queen Elizabeth University Hospital.

The funding will be used to adapt Biospyder’s technology into a diagnostic tool for precision medicine.